User menu

How should we measure nutrition-induced improvements in memory?

Bibliographic reference Benton, D ; Kallus, KW ; Schmitt, JAJ. How should we measure nutrition-induced improvements in memory?. In: European Journal of Nutrition, Vol. 44, no. 8, p. 485-498 (2005)
Permanent URL
  1. Baddeley A (1992) Working memory. Science 255:556–559
  2. Baddeley A (2000) The episodic buffer: a new component of working memory? Trends Cogn Sci 4:417–423
  3. Shallice T, Fletcher P, Frityh CD, Grasby P, Frackowiak RSJ, Dolan RJ (1994) Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368:633–635
  4. Lee ACH, Robbins TW, Graham KS, Owen AM (2002) Pray or Prey? Dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. Neuroimage 16:724–735
  5. Grady CL, Craik FIM (2000) Changes in memory processing with age. Curr Opin Neurobiol 10:224–231
  6. Balota DA, Dolan PO, Duchek JM (2000) Memory changes in healthy older adults. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 395–409
  7. Anderson ND, Craik FIM (2000) Memory in the aging brain. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 411–425
  8. Burke DM, MacKay DG, Worthley JS, Wade E (1991) On the tip-of-the-tongue: What causes word finding failures in young and older adults? J Mem Lang 30:542–579
  9. Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev 24:365–374
  10. Nilsson LG (2003) Memory function in normal aging. Acta Neurol Scand 179 (Suppl):7–13
  11. Park HL, O’Connell JE, Thomson RG (2003) A systematic review of cognitive decline in the general elderly population. Int J Ger Psychiatry 18:1121–1134
  12. Brayne C, Huppert F, Paykel E, Gill C (1992) The Cambridge project for later life: design and preliminary results. Neuroepidemiol 11(Suppl 1):71–75
  13. Lyketsos Constantine G., Chen Li-Shiun, Anthony James C., Cognitive Decline in Adulthood: An 11.5-Year Follow-Up of the Baltimore Epidemiologic Catchment Area Study, 10.1176/ajp.156.1.58
  14. Bischkopf J, Busse A, Angermeyer MC (2002) Mild cognitive impairment—a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 106:403–414
  15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterisation and outcome. Arch Neurol 56:303–308
  16. Newman SK, Warrington EK, Kennedy AM, Rossor M (1994) The earliest cognitive change in a person with familial Alzheimer’s disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer’s disease confirmed at autopsy. J Neurol Neurosurg Psychiatry 57:967–972
  17. Hodges JR (2000) Memory in the dementias. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 441–459
  18. Lorentz WJ, Scanlan JM, Borson S (2002) Brief screening tests for dementia. Can J Psychiatry 47:723–733
  19. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA (2002) The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 50:530–534
  20. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
  21. Feher Edward P., Establishing the Limits of the Mini-Mental State : Examination of 'Subtests', 10.1001/archneur.1992.00530250091022
  22. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JTM (1997) Limitations of the mini-mental state examination for diagnosing dementia in general practice. Int J Geriatr Psychiatry 12:101–108
  23. Pfeiffer Eric, A Short Portable Mental Status Questionnaire for the Assessment of Organic Brain Deficit in Elderly Patients†, 10.1111/j.1532-5415.1975.tb00927.x
  24. Smith G, Della Sala S, Logie RH, Maylor EA (2000) Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 8:311–321
  25. Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH (2000) The prospective and retrospective memory questionnaire (PRMQ): normative data and later structure in a large non-clinical sample. Memory 11:261–275
  26. Wechsler D (1997) Wechsler Memory Scale—3rd UK Edition. Psychological Corporation,New York
  27. Taylor EM (1959) The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, MA
  28. BUSCHKE H., FULD P. A., Evaluating storage, retention, and retrieval in disordered memory and learning, 10.1212/wnl.24.11.1019
  29. O’Connell ME, Tuokko H (2002) The 12-item Buschke memory test: appropriate for use across levels of impairment. Appl Neuropsychol 9:226–233
  30. Wood FB, Ebert V, Kinsbourne M (1982) The episodic-semantic memory distinction in memory and amnesia: clinical and experimental observations. In: Cermak L (ed) Memory and amnesia. Lawrence Erlbaum Associates, Hillsdale, NJ, pp 167–194
  31. Greene JD, Hodges JR (1996) Identification of famous faces and famous names in early Alzheimer’s disease. Relationship to anterograde episodic and general semantic memory. Brain 119:111–128
  32. Uttl B (2005) Measurement of Individual Differences. Psychol Sci 16:460–467
  33. Uttl B (2005) Age-related changes in event-cued prospective memory proper. In: Ohta N, MacLeod CM (eds) Dynamic cognitive processes. Springer-Verlag, Tokyo, pp 273–303
  34. Theisen ME, Rapport LJ, Axelrod BN, Brines DB (1998) Effects of practice in repeated administrations of the Wechsler Memory Scale Revised in normal adults. Assessment 5:85–92
  35. Canizares S, Boget T, Salamero M, Rumia J, Elices E, Arroyo S (2000) Reliability and clinical usefulness of the short forms of the Wechsler memory scale (revised) in patients with epilepsy. Epilepsy Res 41:97–106
  36. Delaney RC, Prevey ML, Cramer J, Mattson RH (1992) Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures. Arch Clin Neuropsychol 7:523–528
  37. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ (1997) Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65:20–29
  38. Rey A (1964) L’examen clinique en psychologie. Presses Universitaires de France
  39. Mitrushina M, Boone KB, Razani LJ, D’Elia LF (2005) Handbook of Normative Data for Neuropsychological Assessment. Oxford University Press, Oxford
  40. Pepeu G, Pepeu IM, Amaducci L (1996) A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res 33:73–80
  41. Nunzi MG, Milan F, Guidolin D, Toffano G (1987) Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration. Neurobiol Aging 8:501–510
  42. Klinkhammer P, Szelies B, Heiss W (1990) Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer’s Disease. Dementia 1:197–201
  43. Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff MPJ (1986) Double-blind randomized controlled study of phosphatidylserine in demented subjects. Acta Neurol Scand 73:136–140
  44. Palmieri G, Palmieri R, Inzoli MR, Agrati AM, Vargiu A (1987) Double-blind controlled trial of phosphatidylserine in subjects with senile mental deterioration. Clin Trials J 24:73–83
  45. Villardita JC, Griolis S, Salmeri G, Nicoletti F, Pennisi G (1987) Multicentre clinical trial of brain phosphatidylserine in elderly subjects with mental deterioration. Clin Trials J 24:84–93
  46. Engel RR, Satzger W, Gunther W, Kathmann N, Bove D, Gerke S, Munch U, Hippius H (1992) Double-blind cross-over study of phosphatidylserine vs. placebo in subjects with early cognitive deterioration of the Alzheimer type. Eur Neuropsychopharmacol 2:149–155
  47. Crook T, Petrie W, Wells C, Massari DC (1992) Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull 28:61–66
  48. Cenacchi Teresa, Bertoldin T., Farina C., Fiori M. G., Crepaldi G., Azzini C. F., Girardello R., Bagozzi B., Garuti R., Vivaldi P., Belloni G., Bordin A., Durando M., Lo Storto M., Bertoni L., Battistoni A., Cacace C., Arduini P., Bonini A., Caramia M. P., Vaglieri G., Brusomini A., Donà G., March A., Campi N., Cannas P., Casson F., Cavallarin G., Delia M., Cristianini G., Louvier O., Mello F., Fameli R., Urbani de Gheltoff N., De Candia O., Nante G., Cattoni C., Forte P. L., Loreggian M., Targa A., Mansoldo G., Noro G., Meggio A., Pedrazzi F., Bonmartini F., Ruggiano C., Peruzza M., Olivari G., Recaldin E., Bellunato C., Rigo G., Marin M., Marinangeli L., Saracino A., Miceli O., Lovo G., Scarpa R., Battistello L., Tomat E., Bernava B., Olivo P., Verga G., Merli G., Zerman A. M., Crivellaro R., Vozza A., Ziliotto G. R., Favaretto V., Allegro L., Cognitive decline in the elderly: A double- blind, placebo- controlled multicenter study on efficacy of phosphatidylserine administration, 10.1007/bf03324139
  49. Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K (1994) Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer’s disease.A neuropsychological, EEG, and PET investigation. Heiss 5:88–98
  50. Maggioni M, Picotti GB, Bondiolotti GP, Panerai A, Cenacchi T, Nobile P, Brambilla F (1990) Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 81:265–270
  51. Crook T. H., Tinklenberg J., Yesavage J., Petrie W., Nunzi M. G., Massari D. C., Effects of phosphatidylserine in age-associated memory impairment, 10.1212/wnl.41.5.644
  52. Jorissen BL, Brouns F, Van Boxtel MP, Ponds RW,Verhey FR, Jolles J, Riedel WJ (2001) The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment Nutr Neurosci 4:121–134
  53. Benton D, Donohoe RT (2005) The influence of phosphatidylserine and carnitine on the mood and the cognitive functioning of those over fifty-five years of age (unpublished findings)
  54. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Geshon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol 2:261–276
  55. Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B (2000) An open trial of plant-source derived phosphatidylserine for treatment of age-related cognitive decline. Isr J Psychiatr Relat Sci 37:302–307
  56. Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T (1997) Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 66:803–809
  57. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Ass 287:3223–3239
  58. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Ass 287:3230–3237
  59. Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS (2002) Vitamin E and cognitive decline in older persons. Arch Neurol 59:1125–1132
  60. Luchsinger JA, Tang MX, Shea S, Mayeux R (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60:203–208
  61. Perrig Walter J., Perrig Pasqualina, Stähelin Hannes B., The Relation Between Antioxidants and Memory Performance in the Old and Very Old, 10.1111/j.1532-5415.1997.tb01476.x
  62. Perkins A. J., Hendrie H. C., Callahan C. M., Gao S., Unverzagt F. W., Xu Y., Hall K. S., Hui S. L., Association of Antioxidants with Memory in a Multiethnic Elderly Sample Using the Third National Health and Nutrition Examination Survey, 10.1093/oxfordjournals.aje.a009915
  63. Ortega RM, Requejo AM, Lopez-Sobaler AM, Andres P, Navia B, Perea JM, Robles F (2002) Cognitive function in elderly people is influenced by vitamin E status. J Nutr 132:2065–2068
  64. Sram RJ, Binkova B, Topinka J, Kotesovec F, Fojtikova I, Hanel I, Klaschka J, Kocisova J, Prosek M, Machalek J (1993) Effect of antioxidant supplementation in an elderly population. Basic Life Sci 61:459–477
  65. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alphatocopherol, or both as treatment for Alzheimer’s disease. New Eng J Med 336:1216–1222
  66. Smith A, Clark R, Nutt D, Haller J, Hayward SA, Perry K (1999) Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharm 14:459–471
  67. Masaki K. H., Losonczy K. G., Izmirlian G., Foley D. J., Ross G. W., Petrovitch H., Havlik R., White L. R., Association of vitamin E and C supplement use with cognitive function and dementia in elderly men, 10.1212/wnl.54.6.1265